Zscaler (ZS) Jumps After Topping Profit, Sale, and Outlook Estimates to Prompt an Upgrade to 'Outperform' at BMO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Zscaler (ZS) Sees Intra-Day Strength
May 27, 2021 10:30 AM EDTZscaler (NASDAQ: ZS) sees intra-day strength. Shares up 0.7%. Shares saw a large gap yesterday following blow-out earnings.
... MoreZscaler (ZS) PT Lowered to $215 at Deutsche Bank
May 26, 2021 6:40 AM EDTDeutsche Bank analyst Patrick Colville lowered the price target on Zscaler (NASDAQ: ZS) to $215.00 (from $233.00) while maintaining a Buy rating.... More
Zscaler (ZS) PT Raised to $215 at Mizuho Securities
May 26, 2021 6:34 AM EDTMizuho Securities analyst Gregg Moskowitz raised the price target on Zscaler (NASDAQ: ZS) to $215.00 (from $200.00) while maintaining a Buy rating.... More
UPDATE: BMO Capital Upgrades Zscaler (ZS) to Outperform
May 26, 2021 2:26 AM EDT(Updated - May 26, 2021 4:40 AM EDT)
BMO Capital analyst Keith Bachman upgraded Zscaler (NASDAQ: ZS) from Market Perform to Outperform with a price target of $225.00 (from $202.00).
The analyst comments "We have stated on more than one occasion that ZS... More
After-Hours Stock Movers 05/25: (PIRS) (INSE) (ZS) Higher; (TVTX) (JWN) (PACK) Lower (more...)
May 25, 2021 5:57 PM EDTAfter-Hours Stock Movers:
Pieris Pharma (NASDAQ: PIRS) 46% HIGHER; adds to 103% intra-day surge on a collaboration and license agreement with Genentech, which includes $20 million as an upfront payment and is eligible to receive more than $1.4 billion in additional potential milestone payments plus royalties.
Travere Therapeutics, Inc. (NASDAQ: TVTX) 10% LOWER; today provided a regulatory update for its sparsentan program in focal segmental glomerulosclerosis (FSGS). Following achievement of the interim proteinuria endpoint in the ongoing Phase 3 DUPLEX... More
Zscaler (ZS) Tops Q3 EPS by 8c, Offers Q4 Guidance
May 25, 2021 4:08 PM EDTZscaler (NASDAQ: ZS) reported Q3 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $176.4 million versus the consensus estimate of $163.71 million.
GUIDANCE:
Zscaler sees Q4 2021 EPS of $0.08-$0.09, versus the consensus of $0.09. Zscaler sees Q4... More
Zscaler (ZS) to Acquire Smokescreen Technologies
May 25, 2021 4:00 PM EDTZscaler, Inc. (NASDAQ: ZS) entered into a definitive agreement to acquire Smokescreen Technologies, a leader in active defense and deception technology. Smokescreen's cutting edge capabilities will be integrated into the Zscaler Zero Trust Exchange, further building upon Zscalers ability to precisely detect the most sophisticated, highly targeted attacks, ransomware, and lateral movement attempts. Additionally, Smokescreen will help provide rich threat... More

